Using An Economic Model To Choose Initial Appropriate Antibiotic Therapy Based On Differences In In-Vitro Susceptibility To Ceftolozane/Tazobactam And Piperacillin/Tazobactam
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.1680
https://www.valueinhealthjournal.com/article/S1098-3015(15)03756-0/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
1110
First Page :
A536
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03756-0&doi=10.1016/j.jval.2015.09.1680